You are viewing: Europe Biopreservation Market analysis
Part of: Biopreservation Market (Global)

The Europe Biopreservation Market was valued at $1037 Million in 2024 and projected to reach to $1604.4 Million by 2029, representing a compound annual growth rate of 9.1%. Europe's biopreservation market is poised for sustained expansion through 2029, supported by increasing investments in regenerative medicine, cell therapy, and personalized medicine initiatives.

Europe Biopreservation Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Biopreservation Market Trends and Insights

  • This expansion reflects Europe's strong regulatory framework, advanced healthcare infrastructure, and increasing investment in regenerative medicine and cell therapy research.
  • Europe is positioning itself as a leader in biopreservation technology adoption, driven by stringent quality standards and growing demand from academic institutions, pharmaceutical companies, and biotech firms across the region. The 9.1% compound annual growth rate (CAGR) through 2029 underscores Europe's commitment to preserving biological materials for clinical and research applications.
  • Europe's biopreservation market benefits from established cold chain logistics, favorable reimbursement policies in key markets, and collaborative research initiatives.
  • The region's emphasis on personalized medicine and cell-based therapies continues to accelerate biopreservation adoption, making Europe a critical hub for innovation in tissue banking, cryopreservation, and biobanking solutions..

Key Market Statistics

  • CAGR (2024-2029) 9.1% CAGR
  • Market Size, 2024 ~USD 1037 Million
  • Forecast, 2029 ~USD 1604.4 Million
  • Geography Europe

Europe Biopreservation Market Overview

Market Valuation & Growth :

Europe's biopreservation market is valued at $1,037.0 million in 2024, with a projected CAGR of 9.1% through 2029, reaching $1,604.4 million. This growth trajectory outpaces many global regions, driven by strong regulatory support and healthcare investment.

Regulatory Leadership :

Europe's stringent regulatory framework, including EU guidelines on cell and tissue preservation, establishes the region as a gold standard for biopreservation practices. This regulatory rigor enhances market credibility and drives adoption of compliant preservation technologies.

Regenerative Medicine Hub :

Europe is emerging as a global leader in regenerative medicine and cell therapy research, with significant R&D investments across Germany, UK, and France. This focus accelerates demand for advanced biopreservation solutions to support clinical trials and therapeutic development.

Advanced Healthcare Infrastructure :

Europe's sophisticated healthcare systems, coupled with high healthcare spending and strong biotech ecosystems, create ideal conditions for biopreservation technology adoption. Leading research institutions and hospitals drive innovation and market expansion across the region.

Europe Biopreservation Market Dynamics

  • The region's commitment to advanced healthcare infrastructure and stringent quality standards positions it as a premium market for biopreservation technologies.
  • Key growth drivers include rising demand for stem cell banking, tissue engineering applications, and the expansion of clinical trials utilizing preserved biological materials.
  • European healthcare providers and research institutions are increasingly adopting cryopreservation and other advanced preservation techniques to enhance therapeutic capabilities and patient outcomes. The competitive landscape in Europe is characterized by strong participation from both established medical device manufacturers and innovative biotech companies.
  • Regulatory harmonization across EU member states, combined with growing public and private funding for life sciences research, creates favorable conditions for market players.
  • Strategic partnerships between academic institutions and commercial entities are accelerating technology development and commercialization, while increasing awareness of biopreservation benefits among healthcare professionals continues to drive market penetration across the region..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Europe's biopreservation market is valued at $1,037.0 million in 2024 and is projected to reach $1,604.4 million by 2029, representing a 9.1% CAGR.
    • Europe leads in regulatory compliance and quality standards, driving adoption of advanced biopreservation technologies across research and clinical sectors.
    • Growing investment in regenerative medicine, cell therapy, and personalized medicine initiatives is accelerating biopreservation demand throughout Europe.
    • Europe's established cold chain infrastructure and collaborative biobanking networks position the region as a global innovation hub for biopreservation solutions.

    Biopreservation Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment BIOPRESERVATION EQUIPMENT (Product)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.8% from 2024 to 2029
    Largest Segment BIOPRESERVATION MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.45 (2024)
    Revenue Forecast (Billions) ~USD 7.1 (2029)
    Segments Covered Product, Type, Biospecimen, Application, End User, Transplant Type

    Europe Biopreservation Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biopreservation Accessories
    • Biopreservation Equipment
    • Biopreservation Media

    By Type

    • Alarm Monitoring Systems
    • Centrifuges
    • Cryogenic Storage Systems
    • Cryopreservation Media
    • Freezers
    • Hypothermic Preservation Media
    • Incubators
    • Other Biopreservation Equipment
    • Other Equipment
    • Refrigerators
    • Temperature Control Systems
    • Thawing Equipment

    By Biospecimen

    • Human Tissue Samples
    • Organs
    • Other Biospecimens
    • Stem Cells

    By Application

    • Other Applications
    • Research Applications
    • Therapeutic Applications

    By End User

    • Biobanks
    • Gene Banks
    • Hospitals
    • Other End Users

    By Transplant Type

    • Cord Blood Transplants
    • Organ Transplants

    EUROPE: BIOPRESERVATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BIOBANKS374.5415.6451493.7539.6592.8650.7716.49.7
    GENE BANKS2142342552783033293603929
    HOSPITALS1691862022182362572783048.5
    OTHER END USERS1081181291391511621761928.3
    TOTAL865.5953.610371128.71229.61340.81464.71604.49.1

    REST OF EUROPE: BIOPRESERVATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BIOBANKS53.558.463.267.671.877.98389.67.2
    GENE BANKS31333537404245486.5
    HOSPITALS25272830323436396.9
    OTHER END USERS16171819202123245.9
    TOTAL125.5135.4144.2153.6163.8174.9187200.66.8

    Target Audience

    • Biopreservation Technology Manufacturers : Manufacturers need Europe-specific market data to develop localized product strategies, understand regulatory requirements, and identify distribution opportunities across key European markets.
    • Healthcare & Research Institutions : European hospitals, research centers, and academic institutions require market insights to evaluate biopreservation solutions, benchmark procurement decisions, and plan investments in preservation infrastructure.
    • Pharmaceutical & Biotech Companies : Pharma and biotech firms need regional market intelligence to support cell therapy development, clinical trial planning, and commercialization strategies tailored to European regulatory and market conditions.
    • Investment & Private Equity Firms : Investors require comprehensive European market analysis to identify acquisition targets, assess portfolio company growth potential, and evaluate biopreservation sector opportunities across the region.
    • Healthcare Consultants & Advisors : Consultants need detailed European market data to advise clients on market entry strategies, competitive positioning, and growth opportunities within the region's biopreservation ecosystem.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 2852.9 Million · 10.1% wtd CAGR ·
    Asia Pacific
    ~USD 1661.4 Million · 11% wtd CAGR ·
    Latin America
    ~USD 418.5 Million · 8.7% wtd CAGR ·
    Middle East & Africa
    ~USD 334 Million · 8.1% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 202.6 Million
    UKUSD 186.7 Million
    FranceUSD 129.1 Million
    ItalyUSD 98.8 Million
    SpainUSD 72.7 Million
    Rest Of EuropeUSD 97.6 Million

    Country market size visualization

    Germany
    USD 202.6 Million
    UK
    USD 186.7 Million
    France
    USD 129.1 Million
    Italy
    USD 98.8 Million
    Spain
    USD 72.7 Million
    Rest Of Europe
    USD 97.6 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into Europe's biopreservation market with country-level breakdowns for Germany, UK, France, Italy, Spain, and Rest of Europe. Understand market dynamics specific to each major European economy.
    • Competitive Intelligence : Identify key market players, their strategies, and competitive positioning within Europe's biopreservation landscape. Benchmark your organization against regional leaders and emerging competitors.
    • Regulatory & Compliance Insights : Navigate Europe's complex regulatory environment with comprehensive analysis of EU guidelines, national regulations, and compliance requirements affecting biopreservation technology adoption and market entry.
    • Growth Opportunity Assessment : Evaluate high-potential segments within Europe's biopreservation market, including regenerative medicine, cell banking, and tissue engineering. Identify underserved markets and emerging applications for strategic expansion.
    • Investment & Partnership Strategy : Support M&A, partnership, and investment decisions with data-driven analysis of European market trends, growth forecasts, and regional opportunities through 2029.

    Frequently asked questions

    What is the current size of Europe's biopreservation market?

    Europe's biopreservation market was valued at $1,037.0 million in 2024 and is expected to grow to $1,604.4 million by 2029.

    What is the projected growth rate for Europe's biopreservation market?

    Europe's biopreservation market is projected to grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2029.

    What factors are driving growth in Europe's biopreservation market?

    Key drivers include increasing investment in regenerative medicine, cell therapy research, stringent regulatory standards, advanced healthcare infrastructure, and growing demand from pharmaceutical and biotech companies across Europe.

    Which sectors in Europe are adopting biopreservation technologies most rapidly?

    Academic research institutions, pharmaceutical companies, biotech firms, and clinical centers focused on regenerative medicine and personalized medicine are leading biopreservation adoption in Europe.

    How does Europe's biopreservation market compare to global trends?

    Europe's 9.1% CAGR is slightly below the global average of 9.8%, but Europe maintains a leadership position in regulatory compliance, quality standards, and innovation in biopreservation solutions.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are:

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Biopreservation Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
    • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Biopreservation Market Size: Top Down Approach

    Biopreservation Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Biopreservation Market Size: Bottom-Up Approach

    Biopreservation Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

    Market Definition

    Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • Doctors/HCPs
    • Researchers
    • Lab Managers/Technicians
    • End Users/Operators

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
    • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
    • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
    • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Biopreservation market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

    Get the Full Biopreservation Market Report

    Full forecast, segment splits, and company analysis for all Biopreservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status